Abstract

The antifungal susceptibilities of 598 isolates of Candida spp. (bloodstream, other sterile sites) to liposomal amphotericin B (L-AmB) versus amphotericin B (AmB) were determined. Minimal inhibitory concentrations (MICs) were calculated using the Clinical and Laboratory Standards Institute broth microdilution (BMD; M27-A3) method for L-AmB and the E-test method for AmB. The MIC50/MIC90 (µg ml-1) values for L-AmB BMD and AmB E-test were 0.25/1 and 0.19/0.5, respectively. The overall essential agreement (± 2 dilutions) was 91.5%, ranging from 37.5% (Candida lusitaniae) to 100% (Candida glabrata and Candida krusei). Categorical agreement (CA) between the two methods was categorized on the basis of previously published breakpoint (susceptible/resistant MIC cut-off of 1 µg ml-1). The overall CA at the 48-h reading was 97.3%, ranging from 72.7% (C. krusei) to 100% (Candida albicans). Major and very major discrepancies occurred in 2.3% and 0.3%, respectively. Spearman's rho was 0.48 (p < 0.0001). These results demonstrate the utility of the AmB E-test as a surrogate marker to predict the sensibility and resistance of Candida species to L-AmB, and thus to support its use in antifungal treatment.

Autore Pugliese

• Caggiano Giuseppina , Montagna Maria Teresa , De Giglio Osvalda

Tutti gli autori

• CAGGIANO G.;MONTAGNA M.T.;DE GIGLIO O.

Titolo volume/Rivista

Non Disponibile

Anno di pubblicazione

2017

ISSN

0022-2615

ISBN

Non Disponibile

Numero di citazioni Wos

Nessuna citazione

Ultimo Aggiornamento Citazioni

Non Disponibile

Numero di citazioni Scopus

Non Disponibile

Ultimo Aggiornamento Citazioni

Non Disponibile

Settori ERC

Non Disponibile

Codici ASJC

Non Disponibile